CAGE Bio
CA - San CarlosBiotechnology
Focus: CAGE Bio is a pre-revenue biotech platform company leveraging deep eutectic ionic liquids to deliver topical therapeutics across dermatology and infectious disease. Founded in 2020 and headquartered in San Carlos, CA, the company remains early-stage with a focus on formulation science innovation.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Open Jobs
0
About CAGE Bio
AI assessmentNot HiringNo open roles listed right now. Follow CAGE Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from CAGE Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CB-0002B
ErythemaClinical Trials (1)
NCT0449867650 Human Subject Repeat Insult Patch Test
N/AHelp build intelligence for CAGE Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.